Previous studies have shown that IKBKE is associated with inflammatory responses and metabolic diseases and is highly expressed in various malignant tumors, including non-small cell lung cancer, renal clear cell carcinoma, breast cancer, ovarian cancer, and glioma (15). Here, IKBKE is linked to non-small cell lung carcinoma.